Celgene corp /de/ (CELG)
Income statement / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09Sep'08Jun'08
Revenue:
Total revenue

16,982

16,354

15,768

15,281

14,727

14,122

13,579

13,003

12,500

12,196

11,679

11,229

10,812

10,163

9,687

9,256

8,778

8,426

8,021

7,670

7,340

7,033

6,759

6,493

6,185

5,930

5,698

5,506

5,343

5,173

4,990

4,842

4,629

4,290

3,959

3,625

3,315

3,100

2,876

2,689

2,521

2,397

0

0

0

Royalty revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

119

117

115

122

112

108

109

106

108

110

111

108

102

103

0

0

0

Expenses:
Cost of goods sold (excluding amortization of acquired intangible assets)

627

617

592

587

537

498

483

461

455

445

445

438

430

432

422

420

417

405

403

385

375

364

346

340

327

316

307

299

296

316

371

425

461

430

371

306

242

230

213

216

237

260

0

0

0

Research and development

4,621

4,535

4,686

5,673

7,273

7,539

7,123

5,915

4,312

4,618

4,732

4,470

4,111

3,763

3,924

3,697

3,505

2,876

2,222

2,430

2,576

2,486

2,487

2,226

1,968

1,825

1,814

1,724

1,687

1,602

1,526

1,600

1,491

1,388

1,359

1,128

1,002

942

818

794

754

705

0

0

0

Selling, general and administrative

3,197

3,162

3,159

3,250

3,174

3,036

3,185

2,941

2,852

2,942

2,735

2,658

2,581

2,434

2,318

2,305

2,240

2,188

2,063

2,027

1,932

1,883

1,809

1,684

1,605

1,511

1,416

1,373

1,318

1,267

1,249

1,226

1,206

1,131

1,044

950

867

831

788

753

710

694

0

0

0

Amortization of acquired intangible assets

454

472

490

468

420

373

334

329

355

362

449

459

442

418

307

279

254

254

256

258

260

262

262

262

259

240

218

194

207

235

261

289

282

253

230

203

151

125

101

83

100

114

0

0

0

Acquisition/integration related charges and restructuring, net

191

260

158

112

-1,259

-1,311

-1,358

-1,350

88

64

41

38

109

310

317

300

253

28

59

48

102

134

146

171

219

186

213

169

4

-7

-56

-142

-90

-71

-54

47

0

0

0

-

-

-

0

0

0

Total costs and expenses

9,090

9,046

9,085

10,090

10,145

10,135

9,767

8,296

8,062

8,431

8,402

8,063

7,674

7,358

7,289

7,001

6,672

5,753

5,005

5,151

5,247

5,130

5,052

4,685

4,381

4,079

3,970

3,760

3,513

3,414

3,353

3,399

3,350

3,131

2,952

2,636

2,283

2,143

1,926

1,848

1,802

1,775

0

0

0

Operating income

7,892

7,308

6,683

5,191

4,582

3,987

3,812

4,707

4,438

3,765

3,277

3,166

3,137

2,805

2,398

2,255

2,106

2,673

3,016

2,519

2,093

1,902

1,706

1,808

1,804

1,850

1,727

1,746

1,829

1,759

1,637

1,442

1,278

1,158

1,007

989

1,031

956

949

841

718

622

0

0

0

Other income and (expense):
Interest and investment income, net

132

95

66

45

63

88

103

105

81

55

38

30

25

27

29

31

34

32

30

28

28

26

23

22

20

17

16

15

16

22

25

25

26

31

35

44

51

59

73

76

81

81

0

0

0

Equity in gains (losses) of affiliated companies

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-2

-1

-1

-1

-3

-4

0

0

0

Interest (expense)

764

767

767

741

693

627

561

522

507

508

505

500

498

458

383

311

237

202

196

176

154

125

103

91

84

77

69

63

51

44

42

42

42

32

23

12

2

2

1

1

0

1

0

0

0

Other (expense) income, net

-591

-506

-366

337

894

1,011

976

24

-330

-365

-346

-324

-47

-31

74

48

86

83

-28

-43

-132

-105

-78

-73

-2

-17

-18

-17

-2

-8

-13

-6

-23

1

-6

-9

14

21

31

60

55

41

0

0

0

Income before income taxes

6,669

6,130

5,616

4,832

4,846

4,459

4,330

4,314

3,682

2,947

2,464

2,372

2,618

2,342

2,117

2,023

1,988

2,586

2,822

2,327

1,833

1,698

1,549

1,665

1,738

1,773

1,655

1,681

1,792

1,728

1,606

1,419

1,239

1,157

1,011

1,012

1,095

1,035

1,052

975

850

738

0

0

0

Income tax provision

789

859

871

786

1,954

1,661

1,476

1,374

232

314

334

373

487

416

433

421

333

388

383

327

233

233

204

215

239

222

216

225

189

176

142

102

123

132

110

132

170

175

204

198

190

175

0

0

0

Net Income (Loss) Attributable to Parent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

659

562

0

0

0

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

1,603

1,552

1,463

1,317

1,116

1,024

900

880

0

0

0

-

-

-

-

-

-

Net loss attributable to non-controlling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

0

0

0

-

-

-

-

-

-

-

-

-

-

Net income attributable to Celgene

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,318

1,189

0

0

-

0

-

-

-

-

-

-

-

-

Earnings Per Share [Abstract]
Basic (in dollars per share)

2.38

2.22

2.20

1.52

1.54

1.46

1.13

-0.10

1.26

1.41

1.20

0.55

0.22

0.77

1.03

0.71

-0.04

0.45

0.90

0.76

0.64

0.75

0.34

-0.19

0.45

0.57

0.92

-1.06

0.99

0.84

0.92

0.91

0.83

0.60

0.55

0.44

0.61

0.34

0.51

0.56

0.47

0.31

0.35

0.30

0.27

Diluted (in dollars per share)

2.32

2.16

2.14

1.48

1.50

1.43

1.10

-0.08

1.21

1.36

1.15

0.54

0.21

0.75

0.99

0.69

-0.04

0.43

0.86

0.73

0.61

0.72

0.33

-0.20

0.43

0.56

0.89

-1.04

0.97

0.82

0.90

0.91

0.81

0.59

0.54

0.45

0.60

0.33

0.50

0.54

0.46

0.31

0.35

0.29

0.26

Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic (in shares)

709

706

702

698

702

716

748

773

784

780

779

776

775

775

780

785

791

793

798

800

799

799

811

1,240

824

828

417

2,145

427

436

438

440

452

462

465

469

459

460

459

459

458

459

459

456

442

Weighted Average Number of Shares Outstanding, Diluted

729

726

720

714

719

732

768

796

815

811

811

802

801

801

807

849

791

825

834

835

832

831

845

1,294

857

858

432

2,196

436

445

448

449

459

469

472

476

466

467

467

467

467

467

468

468

466

Net product sales
Total revenue

16,977

16,349

15,758

15,265

14,708

14,101

13,552

12,973

12,471

12,157

11,642

11,185

10,747

10,090

9,600

9,161

8,676

8,321

7,911

7,563

7,233

6,921

6,640

6,362

6,052

5,796

5,569

5,385

5,212

5,043

4,861

4,699

4,497

4,163

3,832

3,508

3,193

2,975

2,750

2,567

2,409

2,284

0

0

0

Product and Service, Other [Member]
Total revenue

5

5

10

16

19

21

27

30

29

39

37

44

65

72

86

95

101

105

109

106

195

172

147

131

125

125

125

121

11

12

12

19

19

18

17

10

13

14

13

13

9

9

0

0

0